This site is intended for healthcare professionals only
LoginRegister
NPPA Expert Committee Recommends Pricing for Abbotts Clarithromycin Tablet, Cautions Firm Over Form ErrorNPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionCDSCO panel Approves Sanofi's Protocol Amendment Proposal for to study Fitusiran
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJohnson & Johnson concludes acquisition of Shockwave Medical
SII, Valneva ink pactModerna gets USFDA nod for mRNA RSV vaccine
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreSanofi concludes acquisition of Inhibrx
PGIMER Chandigarh Gets CDSCO Panel Nod to Study BedaquilinePGIMER Chandigarh Gets CDSCO Panel Nod to Study Bedaquiline
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentCDSCO Panel approves AstraZeneca Pharma's Benralizumab solution for Injection in auto-injector
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi-Regeneron Dupixent recommended for EU approval by CHMP to treat COPD patients
Johnson & Johnson Executive Vice President William N Hait to retireJohnson & Johnson Executive Vice President William N Hait to retire
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic...
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer StudiesResults of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024
Conduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalationConduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalation
X